Balancing the Effects of COVID-19 Against Potential Progression and Mortality in High-risk Prostate Cancer
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
The COVID-19 pandemic is posing challenges in cancer treatment, with priorities, methods, and timing needing to be abruptly redefined. Surgery is recognized as the gold standard treatment for several malignancies, including prostate cancer (PCa). With all health care systems focused on virus control, oncologic surgery has been reduced worldwide.
European Urology , résumé, 2019